Cardiac Left Bundle Branch Block and Pancytopenia in Anorexia Nervosa: Higher Risk with Mirtazapine and Pantoprazole? Case Report

Walder, Adrian; Baumann, Pierre

doi:10.1055/s-0028-1103290

Cited by 4 publications

(3 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Three cases (12,14,16 ) presented with febrile neutropenia, while other cases were asymptomatic. There was concomitant new onset thrombocytopenia in two cases (12,15) . Before attributing neutropenia to medication, other potential causes of neutropenia should be excluded, Case 3.…”

Section: Discussionmentioning

confidence: 94%

“…Huber (20) first including but not limited to viral infection, vitamin B12, folate, autoimmune workup and ideally a bone marrow biopsy. Such investigations were performed only in 3 cases (12,14,15) which included bone marrow biopsy in 2 cases (12,14) . Other cases were presumed to be mirtazapine induced neutropenia given the temporal relationship and improvement of counts after discontinuation of the drug (13,16,17).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Mirtazapine induced neutropenia: A case report and systematic review

Kharel,

Anjum,

Kharel

et al. 2023

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 94%

Section: Discussionmentioning

confidence: 99%

Mirtazapine induced neutropenia: A case report and systematic review

Kharel,

Anjum,

Kharel

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Proton pump inhibitors are often administered to AN patients in a context of gastroesophageal reflux or during tube re-feeding, and they are the first-line treatment because of their efficacy and supposed safety [142]. In fact, proton pump inhibitors have various potential side effects involving bone and renal and digestive functions, and they can interact with psychotropic medications in AN patients [143].…”

Section: Resultsmentioning

confidence: 99%

Medication in AN: A Multidisciplinary Overview of Meta-Analyses and Systematic Reviews

Blanchet

Guillaume

Bat-Pitault

et al. 2019

JCM

View full text Add to dashboard Cite

Drugs are widely prescribed for anorexia nervosa in the nutritional, somatic, and psychiatric fields. There is no systematic overview in the literature, which simultaneously covers all these types of medication. The main aims of this paper are (1) to offer clinicians an overview of the evidence-based data in the literature concerning the medication (psychotropic drugs and medication for somatic and nutritional complications) in the field of anorexia nervosa since the 1960s, (2) to draw practical conclusions for everyday practise and future research. Searches were performed on three online databases, namely MEDLINE, Epistemonikos and Web of Science. Papers published between September 2011 and January 2019 were considered. Evidence-based data were identified from meta-analyses, if there were none, from systematic reviews, and otherwise from trials (randomized or if not open-label studies). Evidence-based results are scarce. No psychotropic medication has proved efficacious in terms of weight gain, and there is only weak data suggesting it can alleviate certain psychiatric symptoms. Concerning nutritional and somatic conditions, while there is no specific, approved medication, it seems essential not to neglect the interest of innovative therapeutic strategies to treat multi-organic comorbidities. In the final section we discuss how to use these medications in the overall approach to the treatment of anorexia nervosa.

show abstract

Current awareness: Pharmacoepidemiology and drug safety

2009

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 23 sections: 1 Reviews; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Teratogens/fetal exposure; 20 Antidiabetic Agents; 21 Contrast Agents; 22 Bone Conservation Agents; 23 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

show abstract

Cardiac Left Bundle Branch Block and Pancytopenia in Anorexia Nervosa: Higher Risk with Mirtazapine and Pantoprazole? Case Report

Cited by 4 publications

References 7 publications

Mirtazapine induced neutropenia: A case report and systematic review

Mirtazapine induced neutropenia: A case report and systematic review

Medication in AN: A Multidisciplinary Overview of Meta-Analyses and Systematic Reviews

Current awareness: Pharmacoepidemiology and drug safety

Contact Info

Product

Resources

About